Background
Vitamin D deficiency is associated with cancer and autoimmune diseases, but little is known about the association between vitamin D and antinuclear antibodies (ANA), a biomarker of immune dysfunction in healthy populations. The objective of this study was to determine if vitamin D deficiency is associated with ANA in middle age and older U.S. adults.
Methods
A cross-sectional analysis using the National Health and Nutrition Examination Survey (NHANES) 2001-2004 was conducted. Data was available for 1,012 adults aged 50 years and older. Serum 25-hydroxyvitamin D levels were measured by radioimmunoassay. ANA was measured in a 1:80 dilution of sera by immunofluorescence using HEp-2 cells (seropositive =3 or 4+).
Results
Greater vitamin D deficiency was associated with higher ANA prevalence in the unadjusted (ptrend = 0.0002) logistic regression model and after adjustment for sex, age, education, race/ethnicity, season and NHANES cycle (ptrend=0.04). After adjustment, those with severe vitamin D deficiency (<10 ng/ml) had 2.99 (95%CI: 1.25, 7.15) times the odds of ANA compared to having normal vitamin D levels (≥30 ng/ml), while deficient and insufficient individuals had twice the odds of ANA.
Conclusion
Among U.S. residents aged 50 and older, vitamin D deficiency was associated with higher prevalence of ANA. Vitamin D sufficiency may be important for preventing immune dysfunction in older populations.
Impact
Our findings support the growing evidence that vitamin D is an important immune modulator. Vitamin D deficiency in older adults may increase vulnerability to cancer by contributing to immune dysfunction.